Can Catalytic Studies of BRCA Lead to New Drug Developments?
Yes, understanding the catalytic mechanisms of BRCA proteins can lead to the development of novel drugs. By elucidating how these proteins facilitate DNA repair, researchers can design molecules that either enhance or inhibit these catalytic processes. For instance, enhancing BRCA function could protect normal cells from DNA damage, while inhibiting BRCA function in cancer cells could make them more susceptible to existing therapies.
